Skip to content

Roivant Sciences ROIV Cash Flow Statement

TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25TTM Q4 '24
-$955.47M-82.4%-$523.69M+17.9%-$637.58M-99.9%-$318.93M-379%
$3.35M-19.0%$4.14M-35.0%$6.37M-38.1%$10.29M-26.9%$14.07M-21.3%
$346.17M-1.8%$352.48M+6.4%$331.17M+3.2%$321.02M+11.1%$289.03M+14.6%
-$750.35M+1.2%-$759.1M+1.4%-$769.86M+9.5%-$851.01M-1.4%-$839.45M-8.3%
$14.52M+89.3%$7.67M+66.8%$4.6M+11.2%
$853.14M-34.0%$1.29B+29.6%
-$746.95M+38.8%-$1.22B-17.0%
-$758.56M+1.1%-$766.86M+2.2%-$784.38M+8.7%-$858.67M-1.7%-$844.05M-8.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Roivant Sciences generate?
Roivant Sciences (ROIV) generated -$750.3M in operating cash flow over the trailing twelve months.
What is Roivant Sciences's free cash flow?
After $14.0M of capital expenditures, Roivant Sciences's free cash flow was -$758.6M over the trailing twelve months, up 10.1% year over year.
Where does Roivant Sciences's cash flow data come from?
Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.